Lantheus Biosciences LTD.

England Life Molecular Imaging, LIMITED

UEI
FKMRJTNYMPZ1
CAGE
U13Y8
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
Arena Business Centre, 25 Barnes Wallis Rd, Fareham PO15 5TS, UK
Website
lantheus.com
Founded
1956
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Lantheus Biosciences LTD.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
The purpose of this delivery order is for the contractor to provide 40 FDA-approved amyloid pet radioligand doses. Contract · 75N95025F00001 National Institute on Drug Abuse $60,000
TAU doses Contract · 75N95024F00001 National Institute on Drug Abuse $43,900
Amyloid doses Contract · 75N95024F00002 National Institute on Drug Abuse $90,000
Amyloid doses Contract · 75N95023F00002 National Institute on Drug Abuse $60,000
PI-2620 TAU for the national institute on aging Contract · 75N95023F00001 National Institute on Drug Abuse $86,000

About Lantheus Biosciences LTD.

Life Molecular Imaging LIMITED is a for-profit corporate entity headquartered in the United Kingdom, registered in SAM.gov since 2016, with expertise in manufacturing radiopharmaceuticals and molecular imaging technologies. The company specializes in producing FDA-approved amyloid and tau protein positron emission tomography (PET) radioligand doses, which are critical for advanced medical research focused on understanding brain pathology and aging processes. Positioned as a parent organization, Life Molecular Imaging LIMITED operates from its Arena Business Centre location in Fareham, UK, and maintains a operational presence in Sterling, Virginia to support federal government contract work.

The company has consistently provided specialized imaging services to federal health research agencies, primarily the National Institute on Aging (NIA) and the National Institute of Mental Health (NIMH). Their federal contract awards have been predominantly focused on delivering precise medical research materials, including specific quantities of amyloid and tau protein PET radioligand doses. These contracts, ranging from $43,900 to $90,000, have supported critical research initiatives like the Baltimore Longitudinal Study of Aging. None of the company's federal contract awards have included set-aside designations, and they have been awarded as firm fixed-price delivery orders or purchase orders, demonstrating a straightforward and targeted approach to fulfilling federal research requirements.

Life Molecular Imaging LIMITED holds a significant single award indefinite delivery contract with the National Institute on Aging valued at $1,900,000, with an ultimate completion date of September 14, 2028. This primary indefinite delivery vehicle (IDV) is specifically designed to support the acquisition of FDA-approved amyloid and second-generation tau PET radioligand doses for measuring brain pathology. Task orders issued to date under this IDV have totaled approximately $146,000, covering tau protein PET imaging services and amyloid doses. The contract directly supports the NIA's mission of understanding aging processes and extends the agency's capability to characterize longitudinal brain changes through advanced molecular imaging techniques, positioning Life Molecular Imaging LIMITED as a critical research partner in neurological and aging studies.

Quick answers

What is Lantheus Biosciences LTD.'s UEI?

Lantheus Biosciences LTD.'s Unique Entity ID (UEI) in SAM.gov is FKMRJTNYMPZ1.

What is Lantheus Biosciences LTD.'s CAGE code?

Lantheus Biosciences LTD.'s CAGE code is U13Y8.

What is Lantheus Biosciences LTD.'s primary NAICS code?

Lantheus Biosciences LTD.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Lantheus Biosciences LTD. located?

Lantheus Biosciences LTD.'s physical address in SAM.gov is Arena Business Centre, 25 Barnes Wallis Rd, Fareham PO15 5TS, UK.

Is Lantheus Biosciences LTD. registered in SAM.gov?

Yes. Lantheus Biosciences LTD.'s SAM.gov registration is active through May 17, 2027.

What is Lantheus Biosciences LTD.'s most recent federal award?

Lantheus Biosciences LTD.'s most recent federal contract award is The purpose of this delivery order is for the contractor to provide 40 FDA-approved amyloid pet radioligand doses (75N95025F00001), from National Institute on Drug Abuse, on September 15, 2025.

On GovTribe

See Lantheus Biosciences LTD.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors